The effect of reiki on pain in women undergoing non-emergency caesarean sections
| ISRCTN | ISRCTN79265996 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN79265996 |
| Protocol serial number | REB#-08-030 |
| Sponsor | The Hospital for Sick Children (Canada) |
| Funder | Investigator initiated and funded (Canada) |
- Submission date
- 14/04/2009
- Registration date
- 27/05/2009
- Last edited
- 30/12/2020
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Pregnancy and Childbirth
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Plain English summary of protocol
Not provided at time of registration
Contact information
Dr Gideon Koren
Scientific
Scientific
Professor of Pediatrics, Pharmacology, Pharmacy, Medicine and Medical Genetics
Clinician-Scientist
The Hospital for Sick Children
Division of Clinical Pharmacology, Rm 8232
555 University Ave
Toronto
M5G 1X8
Canada
| Phone | +1 416 813 1500 ext. 5781 |
|---|---|
| gkoren@sickkids.ca |
Study information
| Primary study design | Interventional |
|---|---|
| Study design | Randomised controlled trial |
| Secondary study design | Randomised controlled trial |
| Study type | Participant information sheet |
| Scientific title | The effect of reiki on pain in women who will undergo non-emergency caesarean sections and the effect of genetic variation on the use of codeine: a randomised controlled trial |
| Study acronym | REPA |
| Study objectives | Can reiki reduce pain after caesarean section by more than 25%? |
| Ethics approval(s) | St. Michael's Hospital Ethics Review Board approved on the 12th May 2008 (ref: 08-030) |
| Health condition(s) or problem(s) studied | Pain levels after caesarean section |
| Intervention | 1. Control group: usual care 2. Reiki Group: usual care plus 20 minutes of Remote Reiki Duration: three days while in the hospital. |
| Intervention type | Other |
| Primary outcome measure(s) | Visual Analogue Scale for pain in movement, at day 1, day 2 and day 3 (amended as of 10/08/09; initial outcome timepoints were 'after 72 hours in hospital'). |
| Key secondary outcome measure(s) | 1. Visual Analogue Scale for pain (in rest) 2. Pain medication (codeine consumption/kg) 3. Return time to normal activities All measured at day 1, day 2 and day 3 (amended as of 10/08/09; initial outcome timepoints were 'after 72 hours in hospital'). |
| Completion date | 30/04/2009 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Adult |
| Lower age limit | 18 Years |
| Sex | Female |
| Target sample size at registration | 80 |
| Total final enrolment | 80 |
| Key inclusion criteria | 1. Informed consent 2. Planned caesarean section 3. Pregnant women aged 18 - 48 years |
| Key exclusion criteria | Does not meet with inclusion criteria |
| Date of first enrolment | 30/06/2008 |
| Date of final enrolment | 30/04/2009 |
Locations
Countries of recruitment
- Canada
Study participating centre
Professor of Pediatrics, Pharmacology, Pharmacy, Medicine and Medical Genetics
Toronto
M5G 1X8
Canada
M5G 1X8
Canada
Results and Publications
| Individual participant data (IPD) Intention to share | No |
|---|---|
| IPD sharing plan summary | Not provided at time of registration |
| IPD sharing plan |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Results article | results | 26/02/2011 | 30/12/2020 | Yes | No |
| Participant information sheet | Participant information sheet | 11/11/2025 | 11/11/2025 | No | Yes |
Editorial Notes
30/12/2020: The following changes have been made:
1. Publication reference added.
2. The final enrolment number has been added from the reference.
